CED-3, a protein that is essential for programmed cell death, also has an unexpected role in the regulation of non-apoptotic genes during normal development.
Sydney Brenner really nailed it when he proposed that the small nematode, C. elegans, be adopted as a model organism. The ease with which genes can be mutated in these worms, combined with the fact that all worms pass through an essentially identical sequence of events as they grow and mature, has allowed researchers to use C. elegans to identify genes that control development (Jorgensen and Mango, 2002). Notably, many of the subjects that C. elegans has become a famous model for have been studied independently, and surprisingly little overlap has been found between them. Therefore, it is extremely informative when genes central to the function of one of these processes are found to ‘moonlight’ in other gene regulatory pathways. Another example of this phenomenon has just been published in eLife by Min Han and co-workers at the University of Colorado in Boulder, including Benjamin Weaver and Rebecca Zabinsky as joint first authors: they have shown that a protein called CED-3, which is a key regulator of the programed cell death pathway or ‘apoptosis’, works with the machinery involved in microRNA-mediated gene regulation to control normal animal development (Weaver et al., 2014).
The first indication of this functional overlap came from a genome-wide RNAi screen, a technique used to systematically look at the effects of reducing the activity of particular genes. During normal development, the expression level of many genes involved in diverse biological processes is controlled by microRNA molecules. These microRNAs often work in large complexes. Mutations in either ain-1 or ain-2, two components of the microRNA effector complex, formally known as the microRNA-Induced Silencing Complex (miRISC), cause large numbers of small developmental defects (Ding et al., 2005; Zhang et al., 2007). Weaver, Zabinsky et al. have now identified 118 genes that, when their activity is reduced, make these defects much worse. These genes encode a broad spectrum of proteins, an observation that is consistent with the number of different roles that microRNAs have in regulating developmental gene expression. These ‘enhancer’ genes likely control normal gene expression in parallel with miRISC complexes (by, for example, producing transcription factors and RNA-processing components) or play important roles in maintaining the integrity of biological pathways that are regulated by microRNAs.
Conspicuous amongst this treasure trove of interesting candidates were a surprising number of genes that have been implicated in controlling apoptosis, a process by which unwanted cells are safely destroyed in a controlled, predictable way. The most striking member of this subgroup was the ced-3 gene, which is recognized throughout biology as one of the central components of the highly conserved apoptotic pathway. The ced-3 gene encodes a caspase—a protein that breaks down other proteins—that is found in many different species and is kept in an inactive state until needed (Miura et al., 1993; Yuan et al., 1993). Once unleashed, the CED-3 caspase is sufficient to initiate apoptosis and, until now, was thought to play a role in only this process (Xue et al., 1996; Conradt and Xue, 2005).
In a series of genetic experiments, Weaver, Zabinsky et al. combined mutant versions of the ced-3 gene with mutations in the miRISC complex components that control microRNA-mediated gene regulation. This enhanced many of the defects that result from just compromising microRNA-mediated gene regulation. These defects are easily observable in growing animals and include those associated with the proper timing of developmental events, the formation of organs, and even behaviour. Therefore, ced-3 and other apoptotic pathway components somehow work in a non-apoptotic role to help keep development on track.
Weaver, Zabinsky et al. then addressed the question of whether the ability of CED-3 to break down proteins is essential to its role in developmental gene regulation (Figure 1). They observed that many of the proteins whose production is regulated by microRNA molecules, including one called LIN-28, contain peptide sequences that are predicted to be CED-3 cleavage sites (Xue et al., 1996). In a series of elegant in vitro experiments, Weaver, Zabinsky et al. demonstrated three findings: that recombinant CED-3 cleaves proteins that contain these sites; that cleavage is inhibited by caspase-specific inhibitors; and that mutating the CED-3 cleavage site found in LIN-28 prevents cleavage from occurring. Next they asked whether expressing a version of LIN-28 that CED-3 cannot break down would reproduce many of the developmental and genetic changes seen when ced-3 activity is lost. They found that expressing the modified version of LIN-28 not only caused the nematodes to grow more slowly, it also altered the order or patterns in which specific developmental processes normally occur.
As with all provocative hypotheses, the proposal put forward by Weaver, Zabinsky et al. raises a number of additional questions. For example, how conserved is this mechanism in biology? Are the protein products of major microRNA targets enriched for putative CED-3 cleavage sites? How many of the remaining 117 candidates derived from the ain-1 or ain-2 enhancer screens are going to be as interesting or as exciting as ced-3? Given the breadth and complexity of microRNA-mediated gene regulation, we can be sure that there will be several.
Programmed cell deathWormbook, 10.1895/wormbook.1.32.1.
The art and design of genetic screens: caenorhabditis elegansNature Reviews Genetics 3:356–369.https://doi.org/10.1038/nrg794
CED-3 caspase acts with miRNAs to regulate non-apoptotic gene expression dynamics for robust development in C. eleganseLife 3:e04265.
- Version of Record published: December 30, 2014 (version 1)
© 2014, Aguirre-Chen and Hammell
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
Precise control and maintenance of population size is fundamental for organismal development and homeostasis. The three cell types of the mammalian blastocyst are generated in precise proportions over a short time, suggesting a mechanism to ensure a reproducible outcome. We developed a minimal mathematical model demonstrating growth factor signaling is sufficient to guarantee this robustness and which anticipates an embryo's response to perturbations in lineage composition. Addition of lineage-restricted cells both in vivo and in silico, causes a shift of the fate of progenitors away from the supernumerary cell type, while eliminating cells using laser ablation biases the specification of progenitors toward the targeted cell type. Finally, FGF4 couples fate decisions to lineage composition through changes in local growth factor concentration, providing a basis for the regulative abilities of the early mammalian embryo whereby fate decisions are coordinated at the population level to robustly generate tissues in the right proportions.
Lineage specification is governed by gene regulatory networks (GRNs) that integrate the activity of signaling effectors and transcription factors (TFs) on enhancers. Sox17 is a key transcriptional regulator of definitive endoderm development, and yet, its genomic targets remain largely uncharacterized. Here, using genomic approaches and epistasis experiments, we define the Sox17-governed endoderm GRN in Xenopus gastrulae. We show that Sox17 functionally interacts with the canonical Wnt pathway to specify and pattern the endoderm while repressing alternative mesectoderm fates. Sox17 and β-catenin co-occupy hundreds of key enhancers. In some cases, Sox17 and β-catenin synergistically activate transcription apparently independent of Tcfs, whereas on other enhancers, Sox17 represses β-catenin/Tcf-mediated transcription to spatially restrict gene expression domains. Our findings establish Sox17 as a tissue-specific modifier of Wnt responses and point to a novel paradigm where genomic specificity of Wnt/β-catenin transcription is determined through functional interactions between lineage-specific Sox TFs and β-catenin/Tcf transcriptional complexes. Given the ubiquitous nature of Sox TFs and Wnt signaling, this mechanism has important implications across a diverse range of developmental and disease contexts.